2.3. Efficacy and Safety Evaluation
Dyspepsia, dyspepsia
SECONDARY
The primary efficacy endpoint was the mean change in the Short-Form Leeds Dyspepsia Questionnaire (SF-LDQ) scores from baseline to treatment week 8. The SF-LDQ is a shortened version of the Leeds dyspepsia questionnaire, a tool used to assess the severity and impact of dyspepsia on an individual’s daily life [The secondary efficacy endpoint was the mean change in Short-Form-12 (SF-12) scores from baseline to treatment week 8. The SF-12 is a shortened version of the 36-item Short-Form Health Survey, which is a widely used tool for assessing health-related quality of life [